← Back to Search

Intensive Bimanual Therapy for Cerebral Palsy

N/A

Recruiting

Research Sponsored by Laval University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Having a diagnosis of cerebral palsy or spastic hemiparesis encephalopathy

Having sensorimotor deficits of one or both upper limb (spastic hemiparesis with a dominance on one side of the body; Manual Ability Classification System (MACS) level 1, 2 or 3)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured 6-month post-intervention.

Awards & highlights

No Placebo-Only Group

Summary

This trial will help researchers understand if an intensive bimanual therapy can improve arm movement and usage in everyday life for people with cerebral palsy.

Who is the study for?

This trial is for children with cerebral palsy who can understand and perform study tasks, have sensorimotor deficits in one or both arms (with a preference on one side), and are classified as MACS level 1 to 3. It's not for those with uncorrected vision issues, other major health problems that could interfere, or recent Botox injections in the arms.

What is being tested?

The trial studies intensive bimanual therapy's effect on arm movement and everyday use of the most affected arm in kids with cerebral palsy. It also looks at how brain imaging might predict outcomes from this therapy.

What are the potential side effects?

Since this intervention involves physical therapy rather than medication, typical side effects may include muscle soreness or fatigue following sessions. The specific risks will depend on each child's condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with cerebral palsy or spastic hemiparesis.

Select...

I have movement difficulties in one or both of my arms.

Select...

I can understand and follow the study's tasks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured 6-month post-intervention.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured 6-month post-intervention.

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured 6-month post-intervention. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Clinical evaluation - Assisting Hand Assessment (AHA)

Clinical evaluation - Box and Blocks Test (BBT)

Clinical evaluation - Jebsen Taylor Test of Hand Function (JTTHF)

+9 more

Secondary study objectives

Self-assessments - Canadian Occupational Performance Measure (COPM)

Self-assessments - Children's Hand-use Experience Questionnaire (CHEQ)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: MANUSExperimental Treatment1 Intervention

Children and youth living with cerebral palsy will take part in a 60-hour intensive bimanual therapy at Peps at Université Laval, during which they will play games and exercise to promote spontaneous use of the most affected hand. Participants will take part to pre-evaluation and 1-week and 6-month post-intervention.

0 / 3Eligibility criteria met